On March 16, 2026, the Local Division of the Unified Patent Court in Düsseldorf issued a decision that certain uses and designs of IPG Photonics’ adjustable‑mode‑beam (AMB) lasers infringe European Patent 2,624,031. The ruling applies to AMB laser products sold in Germany, France and Italy and is estimated to affect less than 1 % of the company’s total sales.
IPG Photonics said it will implement contingency measures for affected customers while appealing the decision and pursuing other legal remedies. The company emphasized that the ruling does not involve other laser models and that its broader product portfolio remains available.
This decision marks the second adverse ruling against IPG’s AMB technology. A prior UPC decision in Mannheim on a different patent (European Patent 2,951,625) was also brought by Trumpf affiliates, and IPG plans to appeal that case as well. The ongoing legal dispute underscores the competitive tension between IPG and Trumpf in the laser market.
IPG’s Q4 2025 results, released earlier this year, showed revenue of $274.4 million, up 17 % year‑over‑year, and an adjusted earnings per share of $0.46, well above analyst expectations. The company guided for Q1 2026 revenue of $235 million to $265 million and EPS of $0.10 to $0.40, reflecting confidence in continued demand.
Dr. Mark Gitin, CEO, highlighted the company’s execution on strategic initiatives, noting growth in additive and battery‑manufacturing segments and a stabilization of industrial demand. He also underscored IPG’s expansion into high‑growth areas such as medical, micromachining and defense, citing a recent Lockheed Martin order for CROSSBOW counter‑UAS laser systems.
While the legal ruling is a setback, its limited financial impact and the company’s proactive appeal strategy mitigate short‑term risk. The broader portfolio remains unaffected, and IPG’s strong financial performance and strategic focus suggest that the ruling will not materially alter the company’s growth trajectory.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.